ClinicalTrials.gg
Sign In

Heart Septal Defects, Atrial clinical trials

The registry lists 84 studies for Heart Septal Defects, Atrial across more than 10 countries. 21 are recruiting or about to start. 45 of them are mainly about Heart Septal Defects, Atrial (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-13. Counting its narrower condition Foramen Ovale, Patent too: 197 studies, 60 open.

Get an email when these change. Save the Heart Septal Defects, Atrial studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
39
Status unknown
14
Not yet recruiting
11
Recruiting
9
Terminated
5
Active, not recruiting
3

Phase

Phase 4
8
Phase 3
7
Phase 2
3
Phase 1
2
Early Phase 1
1

Where

United States
24
Germany
11
China
9
France
7
Egypt
4
Switzerland
4

Who runs them

Lifetech Scientific (Shenzhen) Co., Ltd. (6) · Abbott Medical Devices (4) · W.L.Gore & Associates (3) · National Heart, Lung, and Blood Institute (NHLBI) (3) · Carag AG (3) · University Health Network, Toronto (2) · Universitaire Ziekenhuizen KU Leuven (2) · Duke University (2)

What is being tested here

Drugs under test in Heart Septal Defects, Atrial studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Dexmedetomidine113
Thiamine001
Citrulline001
Fluorescein001
Clopidogrel001
Ketofol001
Bosentan011
Articaine hydrochloride001

Coming up

0phase 3 studies under way
9studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 9

Who these studies take

Of the 9 Heart Septal Defects, Atrial studies recruiting now, 4 (44%) set no upper age limit and 3 (33%) stop at 75 or younger. 5 (56%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 9
AgeWomenMen
105 (56%)5 (56%)
188 (89%)8 (89%)
307 (78%)7 (78%)
407 (78%)7 (78%)
507 (78%)7 (78%)
657 (78%)7 (78%)
756 (67%)6 (67%)
854 (44%)4 (44%)

Across all 84 studies, recruiting or not: 32% stop at 75 or younger and 27% at 65; 52% take children; 0% are for women only and 2% for men only; 6% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Heart Septal Defects, Atrial studies take

Of 19 interventional studies with no phase under Heart Septal Defects, Atrial, half reached primary completion within 24 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase24 mo13–56 · 19 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 14, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 84. Browse all 84 → or search them.